JAGX beat EPS expectations by 98.20%
Apr 08, 2025, 10:37 AM
0.00%
What does JAGX do
Jaguar Health, a San Francisco-based pharmaceutical company with 49 employees, specializes in plant-derived medicines for gastrointestinal issues in humans and animals, including Mytesi for HIV patients and Canalevia-CA1 for dogs. The company went public on May 13, 2015, and operates through human and animal health segments.
Jaguar Health (JAGX) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Jaguar Health's actual EPS was -$0.34, beating the estimate of -$18.87 per share, resulting in a 98.20% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.